FMS

Fresenius Medical Care Corporation

Fresenius Medical Care Corporation (FMS) is rated C (2.2/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (C); its weakest is Revisions (C-).

Quantitative Factor Evaluation • Updated

Overall Rating
2.2 / 5.0
C
Value
C
Factor Score 2.4 / 5.0
Growth
C
Factor Score 2.4 / 5.0
Profitability
C-
Factor Score 2.0 / 5.0
Momentum
C
Factor Score 2.4 / 5.0
Revisions
C-
Factor Score 1.9 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 13.4
EV / EBITDA 6.2
Rev Growth YoY -5.5%
Gross Margin 26.0%
Price Return 3M 10.3%
Price Return 12M -0.6%
Catalyst Signal 0.00
Market Cap N/A
TTM Revenue N/A
Price / Sales 0.7
ROE 7.8%

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-08-05 C (2.4) C (2.4) C- (2.0) C (2.4) C- (1.9) C (2.2)
2026-08-04 C (2.4) C- (2.0) C- (2.1) C (2.4) C- (1.9) C (2.2)
2026-08-03 C (2.4) C (2.4) C (2.5) C (2.4) C- (2.0) C (2.3)
2026-08-02 C (2.4) C (2.4) C (2.5) C (2.4) C- (1.9) C (2.3)